Lead: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine

Lead: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine

Ever wondered how access to life-saving medication like buprenorphine varies across different communities? This episode of 'This Week in Addiction Medicine from ASAM' dives into the stark racial and ethnic disparities in the geographic availability of buprenorphine. The study, published in the Journal of Addiction Medicine, reveals a concerning trend: as the minority composition of an area increases, the number of buprenorphine prescribers significantly decreases.

In urban areas, there are 45% to 55% fewer prescribers, while rural areas see a drop of 62% to 79%. This disparity highlights a critical need for more equitable access to addiction treatment resources. You'll also hear about other fascinating studies, including the impact of smartphone addiction on well-being and loneliness among university students, and the economic evaluations of opioid overdose prevention centres in North America.

The episode doesn't shy away from tough topics, such as the elevated drug overdose mortality rates among visitors to Florida and the potential of dopamine 3 receptors as biomarkers for opioid use disorder. With a blend of rigorous research and real-world implications, this episode is a must-listen for anyone interested in the complexities of addiction medicine and public health. Don't miss out on these eye-opening discussions—tune in to gain a deeper understanding of the challenges and advancements in addiction treatment.